Frankfurt - Delayed Quote EUR
Paradigm Biopharmaceuticals Limited (P86.F)
0.1690
+0.0160
+(10.46%)
At close: May 2 at 3:29:01 PM GMT+2
Insider Roster
Insider roster data is derived solely from the last 24 months of Form 3 & Form 4 SEC filings.
| Individual or Entity | Most Recent Transaction | Date | Shares Owned as of Transaction Date |
|---|---|---|---|
| Fisher (Helen) Retired | Other | Mar 4, 2024 | 0 |
| Fry (Matthew James) Director (Non-Executive) | Purchase | Oct 14, 2024 | 1,419,830 |
| Fullerton (Christopher Maxwell) Former | Other | Nov 19, 2020 | 70,000 |
| Gaffney (John) Director (Non-Executive) | Purchase | May 11, 2020 | 587,555 |
| Kaufman (Graeme Roy) Non Executive Chairman | Purchase | May 8, 2020 | 1,890,034 |
| Rennie (Paul) Managing Director | Other | Nov 21, 2024 | 20,726,750 |
| Skerrett (Donna M.D.) Director (Executive) | Other | Jan 25, 2022 | 1,094,284 |
Related Tickers
NDTP NDT Pharmaceuticals Inc.
0.0905
0.00%
NBCO Neon Bloom, Inc.
0.0121
0.00%
YECO EV Biologics, Inc.
0.0870
0.00%
STMM Stemcell Holdings, Inc.
0.0600
0.00%
TGRP TRON Group Inc.
0.0300
0.00%
PKTX ProtoKinetix, Incorporated
0.0100
+14.94%
MRZM Marizyme, Inc.
0.0003
0.00%
INTI Inhibitor Therapeutics, Inc.
0.0500
0.00%
SXTPW 60 Degrees Pharmaceuticals, Inc.
0.0570
+3.45%
EMMA Emmaus Life Sciences, Inc.
0.0165
0.00%